220 related articles for article (PubMed ID: 30149960)
1. Association of lymphadenectomy and survival in epithelial ovarian cancer.
Ercelep O; Ozcelik M; Gumus M
Curr Probl Cancer; 2019 Apr; 43(2):151-159. PubMed ID: 30149960
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
Quan C; Chen X; Wen H; Wu X; Li J
BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
[TBL] [Abstract][Full Text] [Related]
3. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
5. Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status.
Gallotta V; Bruno M; Conte C; Giudice MT; Davià F; Moro F; Zannoni GF; Fagotti A; De Bonis M; Capoluongo E; Scambia G; Ferrandina G
Eur J Surg Oncol; 2020 Jul; 46(7):1327-1333. PubMed ID: 32085925
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
[TBL] [Abstract][Full Text] [Related]
7. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.
Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
Gynecol Oncol; 2016 Nov; 143(2):252-257. PubMed ID: 27567053
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
9. The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.
Deng T; Huang Q; Wan T; Luo X; Feng Y; Huang H; Liu J
J Gynecol Oncol; 2021 May; 32(3):e40. PubMed ID: 33825356
[TBL] [Abstract][Full Text] [Related]
10. Survival impact of number of removed para-aortic lymph nodes in stage I epithelial ovarian cancer.
Günakan E; Akıllı H; Kara AT; Altundağ Ö; Haberal AN; Meydanlı MM; Ayhan A
Arch Gynecol Obstet; 2022 Feb; 305(2):459-465. PubMed ID: 34410474
[TBL] [Abstract][Full Text] [Related]
11. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
[TBL] [Abstract][Full Text] [Related]
13. Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study.
Ayhan A; Ozkan NT; Sarı ME; Celik H; Dede M; Akbayır Ö; Güngördük K; Şahin H; Haberal A; Güngör T; Arvas M; Meydanlı MM
J Gynecol Oncol; 2018 Jan; 29(1):e12. PubMed ID: 29185270
[TBL] [Abstract][Full Text] [Related]
14. The insolvable problem; survival effect of lymphadenectomy in advanced stage ovarian cancer.
Bakır MS; Birge Ö; Karadag C; Doğan S; Tuncer HA; Simsek T
Ginekol Pol; 2021; 92(12):829-836. PubMed ID: 33914302
[TBL] [Abstract][Full Text] [Related]
15. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
Takei Y; Takahashi S; Machida S; Taneichi A; Yoshiba T; Takahashi Y; Yoshida C; Saga Y; Matsubara S; Fujiwara H
Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
[TBL] [Abstract][Full Text] [Related]
16. Isolated lymph node recurrence in epithelial ovarian cancer: Recurrence with better prognosis?
Delangle R; Rossard L; Cirier J; Delvallée J; Bendifallah S; Touboul C; Collinet P; Coutant C; Akladios C; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Ballester M; Darai E; Body G; Ouldamer L;
Eur J Obstet Gynecol Reprod Biol; 2020 Jun; 249():64-69. PubMed ID: 32381349
[TBL] [Abstract][Full Text] [Related]
17. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.
Matsuo K; Machida H; Mariani A; Mandelbaum RS; Glaser GE; Gostout BS; Roman LD; Wright JD
J Gynecol Oncol; 2018 Sep; 29(5):e69. PubMed ID: 30022633
[TBL] [Abstract][Full Text] [Related]
18. The impact of lymph node dissection on apparent Stage I epithelial ovarian carcinoma: A population-based study.
Chen Q; Wang S; Lang JH
Int J Gynaecol Obstet; 2021 Sep; 154(3):550-557. PubMed ID: 33507544
[TBL] [Abstract][Full Text] [Related]
19. [Feasibility of No.8p lymphadenectomy for the patients with advanced gastric cancer].
Ye Z; Zeng Y; Wei S; Wang Y; Lin Z; Lin Z; Chen X; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1129-1135. PubMed ID: 30370511
[TBL] [Abstract][Full Text] [Related]
20. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.
Bachmann C; Brucker SY; Kraemer B; Rothmund R; Staebler A; Fend F; Wallwiener D; Grischke EM
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1475-80. PubMed ID: 25739827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
